What is a requirement for patients to receive isotretinoin under the IPledge program?

• A. They must have regular blood tests
• B. They must register and abide by birth control requirements
• C. They must provide proof of insurance
• D. They must maintain a drug diary

Answer: (B)

The requirement for patients to receive isotretinoin under the IPledge program focuses primarily on preventing fetal exposure to the medication, which can cause severe birth defects. Therefore, patients must register for the program and comply with strict birth control requirements. This includes the use of two forms of effective contraception for sexually active female patients. The program aims to ensure that the risks associated with isotretinoin are managed, particularly in women of childbearing age.

While regular blood tests are part of the protocol to monitor for certain side effects and confirm pregnancy status, the cornerstone of the IPledge program's requirements is the focus on contraception adherence to avoid unintended pregnancies. Other options related to proof of insurance or maintaining a drug diary, while important in various contexts, do not fall under the specific requirements of the IPledge program for isotretinoin.